
Monozen SB 250mg/125mg Injection
Marketer
Zencus Pharma
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Monozen SB 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action antibiotic, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, curbing infection spread. Administration must be strictly under a physician's guidance; missed doses should be avoided, and the full treatment course completed regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) require urgent medical help. Prior medication disclosure is essential, especially for those pregnant, breastfeeding, or with pre-existing conditions. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, drowsiness or dizziness necessitates driving cessation. Adequate rest, nutrition, and hydration are crucial for optimal recovery. Monitoring through lab tests may be implemented to assess treatment response.
Primary Ingredients of Monozen SB 250mg/125mg Injection
There is no text provided to rephrase.
Uses of Monozen SB 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Monozen SB 250mg/125mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Monozen SB 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Monozen SB 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Monozen SB 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Monozen SB 250mg/125mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to reproduce. Sulbactam, a beta-lactamase inhibitor, complements this action by neutralizing enzymes that bacteria use to resist antibiotics, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Monozen SB 250mg/125mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Monozen SB 250mg/125mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nonetheless, data from human trials remain scarce.
Breast feedingCAUTION
The administration of Monozen SB 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The injection Monozen SB 250mg/125mg can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Monozen SB 250mg/125mg Injection to individuals with impaired renal function is scarce. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Monozen SB 250mg/125mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Monozen SB 250mg/125mg Injection is unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Monozen SB 250mg/125mg Injection :
Should you inadvertently omit a scheduled dose of Monozen SB 250mg/125mg Injection, seek advice from your physician.
Facts to Know About Monozen SB 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
